MELPHALAN HYDROCHLORIDE
Generic: MELPHALAN HYDROCHLORIDE
Qilu Pharmaceutical Co.Manufacturer
INTRAVENOUSRoute
2019-09-13Original Approval
MELPHALAN HYDROCHLORIDE is FDA application ANDA211463, sponsored by QUAGEN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
PYREXIA
140 reports
2
MUCOSAL INFLAMMATION
136 reports
3
NEUTROPENIA
121 reports
4
FEBRILE NEUTROPENIA
112 reports
5
DIARRHOEA
107 reports
6
PNEUMONIA
105 reports
7
ACUTE GRAFT VERSUS HOST DISEASE
104 reports
8
SEPSIS
104 reports
9
THROMBOCYTOPENIA
101 reports
10
DRUG INEFFECTIVE
98 reports